ArticleVaccines2024

Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia.

Kalkidan Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.